Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors

Nutrition and Cancer

Volumn 62, Issue 2, 2010, Pages 164-174

  Neuhouser, Marian L ^a   Nojomi, Marzieh ^b   Baumgartner, Richard N ^c   Baumgartner, Kathy B ^c   Gilliland, Frank ^d   Bernstein, Leslie ^d,e   Stanczyk, Frank ^d   Ballard Barbash, Rachel ^f   McTiernan, Anne ^a,g  

^a Fred Hutchinson Cancer Research Center   (United States)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DRUG MECHANISM; DRUG USE; FAT INTAKE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE;

ADULT; BREAST NEOPLASMS; DIET; DIETARY FATS; DIETARY FATS, UNSATURATED; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTRONE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; SURVIVORS; TAMOXIFEN; TESTOSTERONE;

EID: 76749168645     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903305359     Document Type: Article

References (59)

1. Berrino F, Bellati C, Secreto G, Camerini E, PalaV, et al.:Reducing bioavailable sex hormones through a comprehensive change in diet: the Diet and Androgens (DIANA) Randomized Trial. Cancer Epidemiol Biomarkers Prev 10, 25-33, 2001.
2. Fowke JH, Longcope C, and Hebert JR: Brassica vegetable consumption shifts estrogenmetabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev 9, 773-779, 2000.
3. McTiernan A, Rajan B, Tworoger S, Irwin M, Bernstein L, et al.: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21, 1961-1966, 2003.
4. Aldercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50, 3-23, 1990.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al.: Cancer statistics, 2007. CA Cancer J Clin 57, 43-66, 2007.
6. Jordan VC, Gapstur S, and Morrow M: Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 93, 1449-1457, 2001.
7. Vogel VG: Recent results from clinical trials using SERMs to reduce the risk of breast cancer. Ann New York Acad Sci 1089, 127-142, 2006.
8. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, et al.: Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 97, 1652-1662, 2005. (Pubitemid 41672231)
9. Prentice RL and Sheppard L: Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1, 81-97, 1990.
10. Prentice RL: Measurement error and results from analytic epidemiology: dietary fat and breast cancer. J Natl Cancer Inst 88, 1738-1747, 1996.
11. Hursting SD, Thornquist M, and Henderson MM: Types of dietary fat and the incidence of cancer at five sites. Prev Med 19, 242-253, 1990.
12. Wu AH, Pike MC, and Stram DO: Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91, 529-534, 1999.
13. Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, et al.: Relation of energy, fat, and fiber intakes to plasma concentrations of estrogens and androgens in premenopausal women. Am J Clin Nutr 64, 25-31, 1996.
14. Food and Nutrition Board, National Academy of Sciences: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids.Washington, DC:NationalAcademy Press, 2005.
15. Bakker N, van't Verr P, and Zock P: Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. EURAMIC study group. Int J Cancer 72, 587-591, 1997.
16. Woutersen RA, Appel MJ, van Garderen-Hoetmer A, and Wijnands MVW: Dietary fat and carcinogenesis. Mutation Res 443, 111-127, 1999.
17. World Cancer Research Fund/American Institute for Cancer: Research Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
18. Nagata C, Takatsuka N, Kawakami N, and Shimizu H: Relationships between types of fat consumed and serum estrogen and androgen concentrations in Japanese men. Nutr Cancer 38, 163-167, 2000. (Pubitemid 32762015)
19. Willett WC and Trichopoulos D: Nutrition and cancer: a summary of the evidence. Cancer Causes Control 7, 178-180, 1996.
20. Boyd NF, Lockwood GA, Greenberg CV, Martin LJ, and Tritchler DL: Effects of a low-fat high-carbohydrate diet on plasma sex hormones in premenopausal women: results from a randomized controlled trial. Canadian Diet and Breast Cancer Prevention Study Group. Br J Cancer 76, 127-135, 1997.
21. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, et al.: Lowfat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295, 629-642, 2006. (Pubitemid 43209065)
22. Wu AH, Stanczyk FZ, Martinez C, Tseng CC, Hendrich S, et al.: A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr 81, 1133-1141, 2005.
23. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, et al.: Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298, 289-298, 2007.
24. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, et al.: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98, 1767-1776, 2006.
25. Rose DP, Chlebowski RT, Connolly JM, Jones LA, andWynder EL: Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Res 52, 5386-5390, 1992.
26. Boyd NF, Greenberg CV, Lockwood GA, Little L, Martin LJ, et al.: Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. J Natl Cancer Inst 89, 488-496, 1997.
27. Djuric Z, Heilbrun LK, Reading BA, Boomer A, Valeriote FA, et al.: Effects of a low-fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. J Natl Cancer Inst 83, 766-769.
28. Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, et al.: Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 23, 774-782, 2005.
29. Irwin ML, Aiello EJ, McTiernan A, Bernstein L, Gilliland FD, et al.: Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors. J Clin Oncol 25, 1061-1066, 2007.
30. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, et al.: SEER Cancer Statistics Review, 1975-2004, NCI based on November 2006 SEER data submission. Washington, DC: National Cancer Institute, 2007.
31. Södergard R, Bäckström T, Shanbhag V, and Carstensen H: Calculation of free and bound fractions of testosterone and estradiol-17b to human plasma proteins at body temperature. J Steroid Biochem 16, 801-810, 1982.
32. Rock CL, FlattSW, Laughlin GA, Gold EB, Thomson CA, et al.: Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev 17, 614-620, 2008.
33. Stanczyk FZ, Lee JS, and Santen RJ: Standardization of steroid hormone assays: why, how and when? Cancer Epidemiol Biomarkers Prev 16, 1713-1719, 2007.
34. Wayne S, Neuhouser ML, Ulrich CM, Koprowski C, Wiggins C, et al.: Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 17, 3224-3232, 2008.
35. Women's Health Initiative Study Group: Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials 19, 61-109, 1998.
36. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, et al.: A databased approach to diet questionnaire design and testing. Am J Epidemiol 124, 453-469, 1986.
37. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, et al.: Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9, 178-187, 1999.
38. Schakel SF, Sievert YA, and Buzzard IM: Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 88, 1268-1271, 1988.
39. Expert Panel on the Identification, Evaluation, and Treatment ofOverweight in Adults:Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Am J Clin Nutr 68, 899-917, 1998.
40. Shils ME, Olson JA, Shike M, and Ross A: Modern Nutrition in Health and Disease, 9th ed. New York: Lippincott Williams and Wilkins, 1998.
41. Dickson RB and Stancel GM: Chapter 8: estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 27, 135-145, 2000.
42. Cavalieri E, Frenkel K, Liehr JG, Rogan E, and Roy D: Chapter 4: estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27, 75-93, 2000.
43. Fowke JH, Longcope C, and Hebert JR: Macronutrient intake and estrogen metabolism in healthy postmenopausal women. Breast Cancer Res Treat 65, 1-10, 2001.
44. Ntukidem N, Nguyen A, Stearns V, Rehman M, Schott A, et al.: Estrogen receptor genotypes, menopausal status and the lipid effects of tamoxifen. Clin Pharmacol Therapeut 83, 702-710, 2008.
45. Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, et al.: Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. J Am Diet Assoc 99, 1212-1221, 1999.
46. Dignam JJ,Wieand K, Johnson KA, Fisher B, Xu L, et al.: Obesity, tamoxifen use and outcomes inwomen with estrogen-receptor positive early-stage breast cancer. J Natl Cancer Inst 19, 1467-1476, 2003.
47. Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, et al.: Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17, 120-129, 1999.
48. Peralta EA, Viegas ML, Louis S, Engle DL, and Dunnington GL: Effect of vitamin E on tamoxifen-treated breast cancer cells. Surgery 140, 607-615, 2006.
49. Constantinou AI, White BEP, Tonetti D, Yang Y, Liang W, et al.: The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Eur J Cancer 41, 647-654, 2005.
50. Liu BL, Edgerton S,Yang XH, Kim AR, Ordonez-Ercan D, et al.: Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res 65, 879-886, 2005.
51. Ju YH, Doerge DR, Allred KF, Allred CD, and Helferich WG: Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogendependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 62, 2474-2477, 2002.
52. Mai Z, Blackburn GL, and Zhou JR: Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogendependent human breast carcinoma inmice. Carcinogenesis 28, 1217-1223, 2007.
53. Chen J, Power KA, Mann J, Cheng A, and Thompson LU: Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Nutr Cancer 58, 162-170, 2007.
54. Sacco SM, Power KA, Chen J, Ward WE, and Thompson LU: Interaction of sesame seed and tamoxifen on tumor growth and bone health of athymic mice. Exp Biol Med 232, 754-761, 2007.
55. Fears TR, Ziegler RG, Donaldson JL, Falk RT, Hoover RN, et al.: Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels. Cancer Epidemiol Biomarkers Prev 11, 758-789, 2002.
56. Klee GG and Heser DW: Techniques to measure testosterone in the elderly. Mayo Clin Proc 75, S19-S25, 2000.
57. Subar A, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al.: Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN Study. Am J Epidemiol 158, 1-13, 2003.
58. Neuhouser ML, Tinker L, Shaw PA, Schoeller DA, Bingham SA, et al.: Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol 167, 1247-1259, 2008.
59. Prentice RL, Sugar E, Wang CY, Neuhouser ML, and Patterson RE: Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease. Public Health Nutr 5, 977-984, 2002.